AstraZeneca’s flagship health equity programme, Healthy Heart Africa (HHA) has run over 67 million hypertension screenings in Nigeria and other African countries in the past 10 years, the company said on Monday.
Hypertension is a leading risk factor for cardiovascular diseases and accounts for a significant portion of noncommunicable disease (NCD) deaths globally.
In Africa, over 27 percent of adults live with hypertension, far above the global average.